NPs Basic Information

Name
Fumitremorgin B
Molecular Formula C27H33N3O5
IUPAC Name*
(1R,2S,12S,15S)-1,2-dihydroxy-7-methoxy-10-(3-methylbut-2-enyl)-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione
SMILES
CC(=CCN1C2=C(C=CC(=C2)OC)C3=C1[C@@H](N4C(=O)[C@@H]5CCCN5C(=O)[C@@]4([C@H]3O)O)C=C(C)C)C
InChI
InChI=1S/C27H33N3O5/c1-15(2)10-12-28-20-14-17(35-5)8-9-18(20)22-23(28)21(13-16(3)4)30-25(32)19-7-6-11-29(19)26(33)27(30,34)24(22)31/h8-10,13-14,19,21,24,31,34H,6-7,11-12H2,1-5H3/t19-,21-,24-,27+/m0/s1
InChIKey
WEIYXEFMCIRZHC-MWGWWEMPSA-N
Synonyms
Fumitremorgin B; Lanosulin; 12626-17-4; Fumitremorgen B; (5ar,6s,12s,14as)-5a,6-dihydroxy-9-methoxy-11-(3-methylbut-2-en-1-yl)-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5h,14h-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14-dione; ITN5B384F8; UNII-ITN5B384F8; 5H,14H-Pyrrolo(1'',2'':4',5')pyrazino(1',2':1,6)pyrido(3,4-b)indole-5,14-dione, 1,2,3,5a,6,11,12,14a-octahydro-5a,6-dihydroxy-9-methoxy-11-(3-methyl-2-butenyl)-12-(2-methyl-1-propenyl)-, (5aR,6S,12S,14aS)-; SCHEMBL3127635; CHEMBL3885413; CHEBI:64531; DTXSID70925478; NA-209B; 5H,14H-Pyrrolo(1'',2'':4',5')pyrazino(1',2':1,6)pyrido(3,4-b)indole-5,14-dione, 1,2,3,5a,6,11,12,14a-octahydro-5a,6-dihydroxy-9-methoxy-11-(3-methyl-2-butenyl)-12-(2-methyl-1-propenyl)-, (5aR-(5a-alpha,6-alpha,12-beta,14a-alpha))-; HY-117313; CS-0065271; C20630; Q27133338; (1R,2S,12S,15S)-1,2-dihydroxy-7-methoxy-10-(3-methylbut-2-enyl)-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione; 1,2-Dihydroxy-7-methoxy-10-(3-methylbut-2-enyl)-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione; 4Q1; 5H,14H-PYRROLO(1'',2'':4',5')PYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-5,14-DIONE, 1,2,3,5A,6,11,12,14A-OCTAHYDRO-5A,6-DIHYDROXY-9-METHOXY-11-(3-METHYL-2-BUTEN-1-YL)-12-(2-METHYL-1-PROPEN-1-YL)-, (5AR,6S,12S,14AS)-
CAS 12626-17-4
PubChem CID 105113
ChEMBL ID CHEMBL3885413
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Indoles and derivatives
        • Subclass: Pyridoindoles
          • Direct Parent: Beta carbolines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 479.6 ALogp: 2.7
HBD: 2 HBA: 5
Rotatable Bonds: 4 Lipinski's rule of five: Accepted
Polar Surface Area: 95.2 Aromatic Rings: 5
Heavy Atoms: 35 QED Weighted: 0.647

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.841 MDCK Permeability: 0.00001130
Pgp-inhibitor: 0.995 Pgp-substrate: 0.959
Human Intestinal Absorption (HIA): 0.763 20% Bioavailability (F20%): 0.219
30% Bioavailability (F30%): 0.965

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.843 Plasma Protein Binding (PPB): 88.58%
Volume Distribution (VD): 1.749 Fu: 6.14%

ADMET: Metabolism

CYP1A2-inhibitor: 0.026 CYP1A2-substrate: 0.094
CYP2C19-inhibitor: 0.74 CYP2C19-substrate: 0.901
CYP2C9-inhibitor: 0.836 CYP2C9-substrate: 0.903
CYP2D6-inhibitor: 0.014 CYP2D6-substrate: 0.144
CYP3A4-inhibitor: 0.79 CYP3A4-substrate: 0.929

ADMET: Excretion

Clearance (CL): 10.393 Half-life (T1/2): 0.136

ADMET: Toxicity

hERG Blockers: 0.126 Human Hepatotoxicity (H-HT): 0.988
Drug-inuced Liver Injury (DILI): 0.981 AMES Toxicity: 0.019
Rat Oral Acute Toxicity: 0.119 Maximum Recommended Daily Dose: 0.992
Skin Sensitization: 0.141 Carcinogencity: 0.696
Eye Corrosion: 0.003 Eye Irritation: 0.005
Respiratory Toxicity: 0.946
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003281 0.761 D06YFA 0.265
ENC001958 0.673 D0W6DG 0.262
ENC003264 0.673 D02IQY 0.250
ENC002260 0.636 D0Y5RZ 0.247
ENC003265 0.596 D01TSI 0.237
ENC000842 0.594 D06HBQ 0.236
ENC002064 0.540 D0Q0PR 0.236
ENC003013 0.534 D0P0RX 0.232
ENC005479 0.521 D0J5TS 0.232
ENC002846 0.484 D0R1RS 0.231
*Note: the compound similarity was calculated by RDKIT.